0000950170-23-043038.txt : 20230816 0000950170-23-043038.hdr.sgml : 20230816 20230816165045 ACCESSION NUMBER: 0000950170-23-043038 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20230814 FILED AS OF DATE: 20230816 DATE AS OF CHANGE: 20230816 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Bullock John CENTRAL INDEX KEY: 0001595347 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-13323 FILM NUMBER: 231178795 MAIL ADDRESS: STREET 1: 251 O'CONNOR RIDGE BLVD. STREET 2: SUITE 300 CITY: IRVING STATE: TX ZIP: 75038 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: DARLING INGREDIENTS INC. CENTRAL INDEX KEY: 0000916540 STANDARD INDUSTRIAL CLASSIFICATION: FATS & OILS [2070] IRS NUMBER: 362495346 STATE OF INCORPORATION: DE FISCAL YEAR END: 1230 BUSINESS ADDRESS: STREET 1: 5601 N MACARTHUR BLVD CITY: IRVING STATE: TX ZIP: 75038 BUSINESS PHONE: 9727170300 MAIL ADDRESS: STREET 1: 5601 N MACARTHUR BLVD CITY: IRVING STATE: TX ZIP: 75038 FORMER COMPANY: FORMER CONFORMED NAME: DARLING INTERNATIONAL INC DATE OF NAME CHANGE: 19931223 4 1 ownership.xml 4 X0508 4 2023-08-14 0000916540 DARLING INGREDIENTS INC. DAR 0001595347 Bullock John 5601 N. MACARTHUR BLVD IRVING TX 75038 true EVP Chief Strategy Officer false Common Stock 2023-08-14 4 S false 43720 65 D 57469 D Common Stock 2023-08-16 5 G false 5000 0 D 52469 D Common Stock 2023-08-14 4 M false 34427 18.82 A 86896 D Common Stock 2023-08-14 4 F false 19547 65.48 D 67349 D Common Stock 2023-08-14 4 S false 14880 65.48 D 52469 D Options (right to buy) 18.82 2023-08-14 4 M false 34427 0 D 2021-01-29 2028-01-29 Common Stock 34427 0 D On 08/16/2023, the reporting person donated 5,000 shares of directly owned shares of common stock to a donor-advised fund, which will use the gifted shares for charitable purposes. This transaction was executed in multiple trades at prices ranging from $65.44 to $65.57; the price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide full information regarding the number of shares and prices at which the transactions were effected upon request to the SEC staff, the issuer, or a security holder of the issuer. Options granted pursuant to 2017 Omnibus Incentive Plan to purchase 11,476 shares became exercisable on 01/29/2019 and 01/29/2020 and 11,475 shares became exercisable on 01/29/2021. /s/ John Bullock 2023-08-16